The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
89 reports and counting
Biolevate Raises €30M Series A for Life Sciences Automation
Biolevate raised a €30 million Series A co-led by RAISE France and Orange Ventures to expand evidence-grade automation for regulated life sciences operations.
Buildots Raises $130M in Round Led by O.G. Venture Partners
Buildots announced a $130M funding round led by O.G. Venture Partners, bringing total funds raised to $297 million.
PatientIQ Raises $30M Series C for Patient Outcomes Intelligence
PatientIQ raised a $30 million Series C led by Hughes and Company to deepen its presence across existing specialties and health systems, expand its real-world evidence platform for medical device and life sciences companies, and build a direct-to-patient commerce experience.
NovaGo Therapeutics Raises $30M Series B for Spinal Cord Injury Study
NovaGo Therapeutics raised a $30 million Series B led by Neurimmune and Pureos Bioventures to advance a proof-of-concept study in acute spinal cord injury.
TYBR Health Raises $30M Series A for Surgical Healing Products
TYBR Health raised a $30 million Series A led by Vensana Capital and Mutual Capital Partners to expand commercial access to its FDA-cleared B3 GEL System.
Emergent Raises $130M Series C at a $1.5B Valuation
AI coding platform Emergent raised a $130 million Series C led by Creaegis and reached unicorn status just over a year after launch.
CatalystSync Networks raises $30M Series B at $133M valuation
CatalystSync Networks secures $30M in Series B funding led by a16z crypto, reaching $133M valuation as it accelerates growth in the developer tools sector.
Light Raises $30M in Growth
Light, a Fintech company based in Paris, France, has raised $30M in Growth from multiple investors.
Ultralytics Raises $30M in Series A
Ultralytics, a AI/ML company based in Los Angeles, CA, has raised $30M in Series A led by Elephant VC.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.